4//SEC Filing
O'Neill Gilmore Neil 4
Accession 0001415889-23-004313
CIK 0001650664other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:30 PM ET
Size
7.2 KB
Accession
0001415889-23-004313
Insider Transaction Report
Form 4
O'Neill Gilmore Neil
DirectorCEO
Transactions
- Award
Common Stock
2023-03-02+50,000→ 136,655 total - Award
Stock Option (right to buy)
2023-03-02+150,000→ 150,000 totalExercise: $8.72Exp: 2033-03-01→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027.
- [F2]This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001742084
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:30 PM ET
- Size
- 7.2 KB